Abstract
No public abstract is available from the verified source records.
Open public full textRights: UNKNOWN · https://www.elsevier.com/tdm/userlicense/1.0/ · Source: journal-auto-sync:external:CROSSREF_ISSN
Beata Toczylowska, Zygmunt Jamrozik, Adam Liebert, Hubert Kwiecinski
Abstract
Rights: UNKNOWN · https://www.elsevier.com/tdm/userlicense/1.0/ · Source: journal-auto-sync:external:CROSSREF_ISSN
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS
10.1038/35097565 · 2001
Matrix metal-loproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis
10.1097/00001756-200011090-00003 · 2000
Increased oxidative damage to DNA in ALS patients
10.1016/s0891-5849(00)00349-x · 2000
Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis
10.1111/j.1600-0404.1993.tb04186.x · 1993
Metabolomic analysis and signatures in motor neuron disease
10.1007/s11306-005-4810-1 · 2005
Plasma biomarkers associated with ALS and their relationship to iron homeostasis
10.1002/mus.21625 · 2010
A candidate biomarker for amyotrophic lateral sclerosis
10.1371/journal.pone.0015133 · 2010
The application of NMR-based metabonomics in neurological disorders
10.1016/j.nurx.2006.05.004 · 2006
An NMR metabolomic investigation of early metabolic disturbances following traumatic brain injury in a mammalian model
10.1002/nbm.980 · 2005
Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia
10.1371/journal.pmed.0030327 · 2006
Changes in concentration of cerebrospinal fluid components in patients with traumatic brain injury
10.1016/j.brainres.2006.05.057 · 2006
Applying proteomics to the diagnosis and treatment of ALS and related diseases
10.1002/mus.21488 · 2009
Metabolite profile of cerebrospinal fluid in patients with spina bifida: a proton magnetic resonance spectroscopy study
10.1097/01.brs.0000152161.08313.04 · 2005
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
10.1080/146608200300079536 · 2000
Standardized method for high-resolution 1H-NMR of cerebrospinal fluid
10.1093/clinchem/41.5.744 · 1995
Further assignment of resonances in 1H NMR spectra of cerebrospinal fluid (CSF)
10.1016/s0014-5793(98)00262-2 · 1998
High resolution NMR spectroscopy of CSF: methodological issues and perspective clinical applications
1991
Centering, scaling, and transformations: improving the biological information content of metabolomics data
10.1186/1471-2164-7-142 · 2006
Application of partial least squares discriminant analysis to two-dimensional difference gel studies in expression proteomics
10.1002/pmic.200400881 · 2005
Urinary metabolomics as a potentially novel diagnostic and stratification tool for knee osteoarthritis
10.1007/s11306-009-0184-0 · 2010
Orthogonal projections to latent structures (O-PLS)
10.1002/cem.695 · 2002
Orthogonal signal correction of near-infrared spectra
10.1016/s0169-7439(98)00109-9 · 1998
Direct orthogonal signal correction
10.1016/s0169-7439(01)00102-2 · 2001
OPLS discriminant analysis: combining the strengths of PLSDA and SIMCA classification
10.1002/cem.1006 · 2006
Metabolic fingerprinting as a diagnostic tool
10.2217/14622416.8.9.1243 · 2007
Brain energetics
2007
Cerebrspinal fluid in clinical practice
2009
Cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients induces degeneration of a cultured motor neuron cell line
10.1016/j.brainres.2009.01.041 · 2009
1H-NMR-based metabolomic profiling of CSF in early amyotrophic lateral sclerosis
10.1371/annotation/2c2f8fce-a5be-40a3-af8f-48f119b2c593 · 2010
Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis
10.1016/j.cca.2010.01.016 · 2010
Unresolved referenced work
2010
Choline levels are increased in cerebrospinal fluid of Alzheimer patients
10.1016/s0197-4580(89)80009-0 · 1989
NMR spectroscopic study on the metabolic fate of [3-(13)C]alanine in astrocytes, neurons, and cocultures: implications for glia-neuron interactions in neurotransmitter metabolism
10.1002/1098-1136(200012)32:3<286::aid-glia80>3.0.co;2-p · 2000
Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis
10.1186/1471-2164-8-26 · 2007
Excitotoxic index – a biochemical marker of selective vulnerability
10.1016/0304-3940(91)90889-2 · 1991
Amino acids acting as transmitters in amyotrophic lateral sclerosis (ALS)
10.1111/j.1600-0404.1999.tb00717.x · 1999
Neurotoxic activity of serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients against some enzymes of glutamate metabolism
2001
Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis
10.3233/jad-2010-100366 · 2010
Amyotrophic lateral sclerosis – electrophysiologic aspects of its pathophysiology and new therapeutic options
2010
CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients
10.1006/neur.1995.0026 · 1995
No additional external references are available.